Mercer Global Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.76M Sell
117,595
-2,408
-2% -$97.5K 0.01% 555
2025
Q1
$4.88M Sell
120,003
-20,084
-14% -$816K 0.01% 546
2024
Q4
$4.74M Sell
140,087
-16,258
-10% -$550K 0.01% 549
2024
Q3
$6.37M Buy
156,345
+8,760
+6% +$357K 0.01% 439
2024
Q2
$5.79M Buy
147,585
+516
+0.4% +$20.3K 0.02% 417
2024
Q1
$6.3M Buy
147,069
+16,514
+13% +$708K 0.02% 405
2023
Q4
$4.84M Sell
130,555
-11,565
-8% -$429K 0.01% 477
2023
Q3
$5.15M Buy
142,120
+58,022
+69% +$2.1M 0.02% 428
2023
Q2
$3M Buy
84,098
+25,301
+43% +$902K 0.01% 600
2023
Q1
$2.03M Buy
58,797
+12,958
+28% +$447K 0.01% 672
2022
Q4
$1.61M Buy
45,839
+6,584
+17% +$231K 0.01% 743
2022
Q3
$1.16M Buy
+39,255
New +$1.16M 0.01% 792
2022
Q2
Sell
-99,022
Closed -$5.39M 1862
2022
Q1
$5.39M Buy
99,022
+11,888
+14% +$647K 0.03% 366
2021
Q4
$4.8M Buy
87,134
+37,492
+76% +$2.07M 0.03% 390
2021
Q3
$2.37M Sell
49,642
-2,736
-5% -$131K 0.02% 554
2021
Q2
$2.61M Buy
52,378
+5,706
+12% +$284K 0.02% 492
2021
Q1
$2.08M Sell
46,672
-5,298
-10% -$236K 0.02% 511
2020
Q4
$2.39M Sell
51,970
-12,689
-20% -$584K 0.03% 382
2020
Q3
$3.04M Buy
64,659
+1,301
+2% +$61.2K 0.05% 292
2020
Q2
$3.23M Sell
63,358
-10,734
-14% -$547K 0.06% 237
2020
Q1
$3.51M Sell
74,092
-31,695
-30% -$1.5M 0.08% 216
2019
Q4
$6.21M Sell
105,787
-4,987
-5% -$293K 0.12% 144
2019
Q3
$5.91M Buy
110,774
+16,209
+17% +$865K 0.14% 133
2019
Q2
$4.73M Buy
94,565
+4,686
+5% +$234K 0.13% 144
2019
Q1
$4.7M Buy
+89,879
New +$4.7M 0.17% 112